RHOA drivers take alternate routes in gastric cancer.

Autor: Benton D; Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA., Chernoff J; Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA.
Jazyk: angličtina
Zdroj: Science signaling [Sci Signal] 2023 Dec 19; Vol. 16 (816), pp. eadk9171. Date of Electronic Publication: 2023 Dec 19.
DOI: 10.1126/scisignal.adk9171
Abstrakt: Oncogenic small guanosine triphosphatases (GTPases) are often characterized by a limited set of activating mutations that affect their intrinsic biochemical function, but RHOA-which is frequently mutated in gastric cancer-appears not to have read the instruction manual. Having previously characterized the Y42C RHOA mutation in gastric cancer, in this issue of Science Signaling , Schaefer et al. take on the slightly less common L57V mutation and find that individual RHOA mutations can have different and unpredictable signaling outcomes.
Databáze: MEDLINE